Bladder Cancer | Tumor

Bladder Cancer Treatment May Negatively Impact Patients’ Psychosocial Well-being

July 29th 2021, 6:00pm


Intravesical therapy for patients with non-muscle invasive bladder cancer was found to have an impact on patients’ social, emotional and physical health.

Vietnam Veteran Discusses Agent Orange Exposure and Bladder Cancer

July 29th 2021, 3:00pm


In this episode of the “CURE® Talks Cancer” podcast, a cancer survivor who served in the Vietnam War shares the story of his Agent Orange exposure and bladder cancer.

Continuing to Smoke After Bladder Cancer Diagnosis Increases Recurrence Risk

July 20th 2021, 6:00pm


Smoking cigarettes could lead to a four-fold increased risk of recurrence in patients with a previous diagnosis of non-muscle invasive bladder cancer.

Glycemic Index, But Not Glycemic Load or Carb Intake, May Increase Bladder Cancer Risk

July 19th 2021, 3:00pm


An analysis showed that glycemic index – but not glycemic load or total carbohydrate intake – significantly increased the risk of developing bladder cancer.

FDA Grants Regular Approval to Padcev for Pretreated Metastatic or Advanced Bladder Cancer

July 9th 2021, 6:43pm


Approximately 18 months after granting Padcev an accelerated approval, the Food and Drug Administration granted a regular approval to the treatment for certain previously treated patients with locally advanced or metastatic urothelial carcinoma.

Patients Should Ask Their Providers About Clinical Trial Results

July 7th 2021, 6:00pm


Results demonstrating the efficacy of Bavencio highlight the importance of incorporating recent clinical trial successes into the treatment conversation.

VA Adds Bladder Cancer as Potential Effect of Agent Orange Exposure

July 7th 2021, 3:00pm


Agent Orange exposure impacted millions of U.S. military personnel during the Vietnam War. The chemical may have led to bladder cancer diagnoses later in life.

Trimodality Treatment Including Keytruda May Provide Non-Surgical Treatment Option for Subset of Bladder Cancer

July 4th 2021, 4:00pm


Keytruda plus gemcitabine and higher doses of radiotherapy showed promising efficacy and safety results in patients with muscle-invasive bladder cancer.

ctDNA Positivity May Improve Post-Surgical Immunotherapy Response in Bladder Cancer

June 30th 2021, 1:00pm


Patients who tested positive for the biomarker circulating tumor DNA (ctDNA) had improved disease-free and overall survival after receiving Tecentriq.

Bladder-Saving Treatment Regimen Shows Promise in Patients with Bladder Cancer

June 10th 2021, 9:00pm


A combination of treatment with bladder-saving surgical resection, Opdivo and chemotherapy yielded positive results in patients with muscle-invasive bladder cancer.